In vitro assays measuring cell phenotypes 167
Proliferation assays were conducted using CellTiter-Glo Luminescent Cell Viability 168 Assay (Promega, Madison, USA) following the manufacturer's protocol. Cells were 169 seeded in triplicate into 96-well plates at a density of 2,000 cells per well. For migration 170 assay, 2x10 4 cells were seeded in an insert (8μm pore size) with serum free media and 171 media with 10% FBS was added in lower chambers. Cells were incubated for 20hrs 172 and fixed with 4% paraformaldehyde and stained with 0.1% crystal violet. For colony 173 formation assay, 2x10 3 cells were seeded into 6-well plates. After 2 weeks, colonies 174 were fixed in 4% paraformaldehyde and stained with 0.1% crystal violet. 175
176

RNA Sequencing and qPCR 177 178
RNA sequencing libraries were prepared using TruSeq RNA Access library kit (Illumina, 179 Inc., San Diego, CA, USA) according to the manufacturer`s protocol. After validation of 180 the libraries, using Agilent DNA screentape D1000 kit on a TapeStation (Agilent 181
Technologies, Santa Clara, CA, USA), the hybridization steps were performed using 182 exome capture probes and streptavidin coated beads. RNA sequencing was performed 183
by HiSeq 2000 (Illumina,San Diego, USA by the Macrogen Incorporated). We 184 processed reads from the sequencer and aligned them to the Homo sapiens (hg19). 185
After aligning reads to genome, Cufflinks v2.2.1 was used to assemble aligned reads 186 into transcripts and to estimate their abundance. The transcript counts in isoform and 187 gene level were calculated, and the relative transcript abundances were measured in 188 FPKM (Fragments Per Kilobase of exon per Million fragments mapped) from Cufflinks. 189 RNA sequencing data of breast cancer was generated through a separate project to 190 characterize the genomic profiles of the primary breast tumor and patient-derived 191 xenograft tumors which will be presented in other reports (IRB No. 1402-054-555) . Committee in Seoul National University Hospital (SNUH-IACUC, 17-0165-S1A0 (1)). To 244 obtain control mouse fatpads, eight-week-old non-tumor-bearing BALB/c mouse was 245 sacrificed and mammary fat pad was resected. To obtain tumor-bearing mouse fat pad, 246 2 X 10 5 4T1 mouse mammary epithelial cancer cells were injected in 6-week-old 247 BALB/c mouse's mammary fat pad. At two weeks after the tumor injection, the mouse 248 was sacrificed and tumor-bearing mammary fatpad was resected. The resected fatpads 249 were fixed with 4% PFA and embedded in paraffin. 250 251 S100A8/A9-overexpressing MCF10A cell line 252
253
The coding sequences of S100A8 and S100A9 were acquired by RT-PCR and cloned 254 into pCDH-GFP and pCDH-RFP vectors. MCF10A cells were transfected with lentivirus 255 S100A8-GFP and S100A9-RFP construct. Among the differentially expressed genes, S100A8 and S100A9 genes were highly 358 upregulated in directly co-cultured MCF10A cells and their increased expression was 359 validated in mRNA and protein levels (Figure 3a and 4a) . When S100A8 and S100A9 360 mRNA levels in normal breast and breast cancer tissues were examined using RNA 361 sequencing data comprised of 65 normal and 68 cancer tissues, both genes were 362 significantly upregulated in breast cancer tissues when compared to normal breast 363 tissues ( Figure 4b) . Furthermore, the mRNA dataset from Finak et al [17] showed that 364 S100A8 and S100A9 genes were significantly upregulated in the adjacent stroma 365 tissues in human breast cancer (Figure 4c) . 366
We then used mouse mammary carcinoma xenograft model to determine whether the 367 induction of S100A8/A9 expression by breast cancer cells also occurs in vivo. BALB/c 368 mouse fatpads were injected with 4T1 murine mammary carcinoma cells and were 369 subsequently harvested. Compared to non-tumor bearing fatpads, mouse mammary 370 epithelial cells and peritumoral stromal cells showed increased expression of both 371 S100A8 and S100A9 (Figure 4d and 4e) . These findings in addition to the above 372 transcriptome data indicate that breast cancer cells induce S100A8/9 expression in 373 tumor microenvironment especially in non-tumorigenic mammary epithelial cells. 374 375 S100A8/A9 upregulation contribute to the phenotypic and molecular changes in 376 the co-cultured MCF10A cells 377
378
To determine the functional importance of S100A8 and S100A9 gene expression in 379 mammary epithelial cells, we established a stable MCF10A cells that overexpress 380 S100A8 and S100A9 genes. Transduction of S100A8 overexpression vector resulted in 381 upregulation of both S100A8 and S100A9 proteins (Additional File 12). S100A8-382 overexpressing MCF10A cells showed higher rate of cell proliferation when compared 383 to the control cells (Figure 5a) . Furthermore, S100A8-overexpressing MCF10A cells 384 showed increased cell migration, invasion, colony formation, and 3-dimensional cell 385 growth which are characteristics of the MCF10A cells directly co-cultured with breast 386 cancer cells. (Figure 5b-5d) . 387
To investigated the effect of S100A8 and S100A9 expression on the signaling pathway 388 activities, we repeated the phosphorylation antibody array in S100A8-overexpressed 389 MCF10A cells (Figure 5e cancer RNA sequencing data are shown. c S100A8/A9 mRNA levels in breast cancer 673 stromal tissues are shown (Finak et al. GSE9014) . d Mouse mammary fatpad tissues 674 30 bearing 4T1 breast cancer cells were stained against S100A8 and S100A9. Lower 675 panels show magnified images of the upper insets. e Non-tumor-bearing mouse fatpad 676 were stained with S100A8 and S100A9. 
